USP Still Discussing Structure Of Medicare Rx Formulary Guidelines
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. Pharmacopeia is aware of speculation that it will elevate the “recommended subdivisions” in its draft guidelines to classes in the final model, but says it has not made a decision and that its expert committee is still discussing the issue.